Literature DB >> 28881507

[Evidence-based guideline for diagnosis and treatment of Henoch-Schonlein purpura nephritis (2016)].

.   

Abstract

Entities:  

Year:  2017        PMID： 28881507     DOI： 10.3760/cma.j.issn.0578-1310.2017.09.003

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN： 0578-1310


× No keyword cloud information.
  8 in total

1.  [Clinical effect and mechanism of total glucosides of paeony in the adjuvant therapy for children with Henoch-Schönlein purpura nephritis: a prospective randomized controlled study].

Authors:  Kuan-Furong Shao; Feng-Jun Guan; Chen Dong
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

2.  Serum levels of degraded monosaccharides in children with Henoch-Schönlein purpura.

Authors:  Zhi-Liang Wang; Kai-Di Sheng; Yi Lin; Qiu-Ye Zhang; Li-Juan Zhang; Hong Chang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

3.  Gut Microbiota Variations between Henoch-Schonlein Purpura and Henoch-Schonlein Purpura Nephritis.

Authors:  Fang Zhou; Qimin Shao; Lihong Jia; Chunyan Cai
Journal:  Gastroenterol Res Pract       Date:  2022-04-14       Impact factor: 1.919

4.  Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children.

Authors:  Ying Zhu; Yang Dong; Lin Wu; Fang Deng
Journal:  BMC Pediatr       Date:  2019-11-04       Impact factor: 2.125

5.  Safety and Efficacy Evaluation of Traditional Chinese Medicine (Qingre-Lishi-Yishen Formula) Based on Treatment of Regular Glucocorticoid Combined with Cyclophosphamide Pulse in Children Suffered from Moderately Severe Henoch-Schonlein Purpura Nephritis with Nephrotic Proteinuria.

Authors:  Lirong Fan; Huimin Yan; Xiaofang Zhen; Xiaoming Wu; Jing Hao; Linyi Hou; Lei Han
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-27       Impact factor: 2.629

6.  Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.

Authors:  Yong-Rui Song; Wan-Liang Guo; Mao Sheng; Qiang Lin; Xue-Ming Zhu; Xiao-Zhong Li
Journal:  BMC Pediatr       Date:  2020-11-02       Impact factor: 2.125

7.  Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience.

Authors:  Qingxiao Su; Yuheng Liang; N A Wang; Zhiyan Dou; Zanhua Rong; Xue Zhao; B O Yu; Yuxue Wang; Xinliang Wang
Journal:  Turk J Med Sci       Date:  2021-08-16       Impact factor: 0.973

Review 8.  Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis.

Authors:  Xuerong Yang; Qi Li; Yuanyuan He; Yulian Zhu; Rou Yang; Xiaoshi Zhu; Xi Zheng; Wei Xiong; Yong Yang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.